Anne Angelillo-Scherrer Selected Research

Interferons

11/2021

Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne Angelillo-Scherrer Research Topics

Disease

16	Hemorrhage 09/2023 - 09/2010
10	Thrombosis (Thrombus) 01/2023 - 02/2005
7	Neoplasms (Cancer) 11/2023 - 01/2014
7	Venous Thromboembolism 09/2023 - 01/2015
6	Thrombocytopenia (Thrombopenia) 09/2022 - 09/2009
5	Hemophilia A (Haemophilia) 03/2021 - 05/2013
4	COVID-19 01/2023 - 11/2021
4	Anemia 01/2018 - 02/2008
3	Pulmonary Embolism 09/2019 - 01/2014
2	Thrombophilia 01/2023 - 07/2022
2	Inflammation (Inflammations) 01/2023 - 01/2022
2	Infections 01/2022 - 11/2004
2	Autoimmune Diseases (Autoimmune Disease) 11/2021 - 10/2020
2	Liver Diseases (Liver Disease) 09/2021 - 12/2018
2	Diabetes Mellitus 01/2017 - 01/2015
2	Thromboembolism 09/2009 - 05/2006
2	Atherosclerosis 02/2009 - 08/2002
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023
1	Hyperhomocysteinemia 01/2023
1	Pneumonia (Pneumonitis) 09/2022
1	Hemoglobinopathies 04/2022
1	Virus Diseases (Viral Diseases) 04/2022
1	Hemolysis 04/2022
1	Peritonitis 01/2022
1	Endotoxemia 01/2022
1	Eosinophilia 01/2021
1	Metrorrhagia (Spotting) 12/2020
1	Disease Susceptibility (Diathesis) 10/2020
1	Plasma Cell Neoplasms 10/2020
1	Pathologic Complete Response 10/2020
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2019

Drug/Important Bio-Agent (IBA)

8	AnticoagulantsIBA 01/2023 - 11/2012
7	Thrombin FDA Link 09/2023 - 09/2009
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2004
4	Heparin (Liquaemin)FDA LinkGeneric 09/2022 - 12/2014
3	Fibrinogen (Factor I)FDA Link 01/2023 - 12/2017
3	Factor VIII (Coagulation Factor VIII)IBA 12/2020 - 05/2013
3	FibrinIBA 01/2020 - 09/2009
3	Thromboplastin (Tissue Factor)IBA 12/2018 - 09/2009
2	Phosphotransferases (Kinase)IBA 11/2023 - 05/2006
2	ThrombomodulinIBA 09/2023 - 09/2021
2	InflammasomesIBA 01/2023 - 01/2022
2	fibrin fragment D (D-dimer)IBA 01/2023 - 01/2017
2	Platelet Factor 4IBA 09/2022 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 04/2022 - 01/2018
2	Hemostatics (Antihemorrhagics)IBA 09/2021 - 01/2019
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2020 - 01/2018
2	Protein CIBA 01/2020 - 09/2009
2	Protein SIBA 01/2020 - 01/2018
2	Factor XII (Hageman Factor)IBA 01/2020 - 01/2017
2	C-Reactive ProteinIBA 09/2019 - 01/2017
2	Prothrombin (Factor II)IBA 10/2017 - 11/2009
2	Vitamin K FDA Link 01/2015 - 08/2011
1	trametinibIBA 11/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2023
1	Deoxyribonucleases (DNase)FDA Link 11/2023
1	Factor Xa InhibitorsIBA 01/2023
1	prothrombin complex concentrates (PPSB)IBA 01/2023
1	apixabanIBA 01/2023
1	edoxabanIBA 01/2023
1	PRT064445IBA 01/2023
1	RivaroxabanIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Deoxyribonuclease I (Nickase)IBA 01/2023
1	HomocysteineIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	AntibodiesIBA 09/2022
1	hemoglobin MontrealIBA 04/2022
1	Uric Acid (Urate)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Rituximab (Mabthera)FDA Link 11/2021
1	Messenger RNA (mRNA)IBA 11/2021
1	ocrelizumabIBA 11/2021
1	InterferonsIBA 11/2021
1	VaccinesIBA 11/2021
1	Interleukin-5 (Interleukin 5)IBA 01/2021
1	emicizumabIBA 12/2020
1	Prednisolone (Predate)FDA LinkGeneric 10/2020
1	Lenalidomide (CC 5013)FDA Link 10/2020
1	Bortezomib (Velcade)FDA Link 10/2020
1	Thalidomide (Thalomid)FDA Link 10/2020
1	Immunomodulating AgentsIBA 10/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020
1	AutoantibodiesIBA 10/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2020
1	Cyclic PeptidesIBA 01/2020
1	Factor X (Stuart Factor)IBA 01/2020
1	ferric chlorideIBA 01/2020
1	SolutionsIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 10/2019
1	pro-brain natriuretic peptide (1-76)IBA 09/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2019
1	Troponin T (Troponin T1)IBA 09/2019

Therapy/Procedure

11	Therapeutics 01/2023 - 02/2005
2	Extracorporeal Membrane Oxygenation 09/2022 - 01/2020
2	Polypharmacy 01/2017 - 01/2015
1	Anticoagulation Reversal 01/2023
1	Transplantation 11/2021
1	Autologous Transplantation 10/2019